远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00512 远大医药

休市中 12-19 16:08:06

8.190

+0.210

+2.63%

最高8.240	最低8.010	成交量706.60万
今开8.040	昨收7.980	日振幅2.88%
总市值290.71亿	流通市值290.71亿	总股本35.50亿
成交额5,774万	换手率0.20%	流通股本35.50亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00512","market":"HK","secType":"STK","nameCN":"远大医药","latestPrice":8.19,"timestamp":1766131686002,"preClose":7.98,"halted":0,"volume":7066000,"delay":0,"floatShares":3549571148,"shares":3549571148,"eps":0.704885,"marketStatus":"休市中","change":0.21,"latestTime":"12-19 16:08:06","open":8.04,"high":8.24,"low":8.01,"amount":57735400,"amplitude":0.028822,"askPrice":8.2,"askSize":500,"bidPrice":8.19,"bidSize":107500,"shortable":3,"etf":0,"ttmEps":0.594325,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":7,"adr":0,"listingDate":819302400000,"exchange":"SEHK","adjPreClose":7.98,"dividendRate":0.031746,"openAndCloseTimeList":[[1766107800000,1766116800000],[1766120400000,1766131200000]],"volumeRatio":1.0401286827350509,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00512","defaultTab":"news","newsList":[{"id":"2592663761","title":"每日卖空追踪 | 远大医药 12月19日卖空量成交31.4万股，卖空比例为4.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592663761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592663761?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133013,"startTime":"0","endTime":"0","summary":"远大医药北京时间12月19日，涨2.63%，卖空量成交31.4万股，较上一交易日减少31.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163121a6b6412e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163121a6b6412e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2592324166","title":"远大医药12月19日主力净流入573.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592324166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592324166?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:16","pubTimestamp":1766132164,"startTime":"0","endTime":"0","summary":"12月19日, 远大医药股价涨2.63%，报收8.19元，成交金额5773.5万元，换手率0.20%，振幅2.88%，量比1.04。远大医药今日主力资金净流入573.4万元，上一交易日主力净流出316.6万元。该股近5个交易日下跌0.98%，主力资金累计净流出1492.8万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入511.8万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162330a45f27c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162330a45f27c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2592313331","title":"Go Global战略再突破 远大医药(00512)自研创新FAP靶点核药美国临床获批 撬动超千亿市场空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2592313331","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592313331?lang=zh_cn&edition=full","pubTime":"2025-12-19 08:27","pubTimestamp":1766104073,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，中国医药创新领域迎来一项具有标杆意义的进展——远大医药自主研发的全球创新放射性核素偶联药物GPN01530正式获得FDA批准在美国开展用于诊断实体瘤的I/II期临床研究。公告显示，GPN01530优化了FAP配体的结构，提高了其在肿瘤组织中的摄取，同时降低其在正常组织中的摄取。近年来，远大医药核药产品在全球大放光彩，屡屡刷新海外临床进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Go Global战略再突破 远大医药(00512)自研创新FAP靶点核药美国临床获批 撬动超千亿市场空间","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2592588111","title":"每日卖空追踪 | 远大医药 12月18日卖空量成交15.85万股，卖空比例为4.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592588111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592588111?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046612,"startTime":"0","endTime":"0","summary":"远大医药北京时间12月18日，涨0.13%，卖空量成交15.85万股，较上一交易日减少86.86%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163118a45a9ea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163118a45a9ea3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2592996689","title":"远大医药(00512)：自主研发的重磅全球创新放射性核素偶联药物 GPN01530 在美国获批开展临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2592996689","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592996689?lang=zh_cn&edition=full","pubTime":"2025-12-17 18:06","pubTimestamp":1765966009,"startTime":"0","endTime":"0","summary":"智通财经APP讯，远大医药 发布公告，集团自主研发的全球创新放射性核素偶联药物 GPN01530 近日获得美国食品药品监督管理局正式批准开展用于诊断实体瘤的 I/II 期临床研究，这标志着集团在核药抗肿瘤诊疗领域的全球化布局上又迈出坚实一步。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","HK0000165453.HKD","BK1161","01530","BK1583","BK1593","00512"],"gpt_icon":0},{"id":"2592969955","title":"【券商聚焦】国元证券维持远大医药(0512.HK)“买入”评级 指核药管线推动业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2592969955","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592969955?lang=zh_cn&edition=full","pubTime":"2025-12-16 09:37","pubTimestamp":1765849022,"startTime":"0","endTime":"0","summary":"金吾财讯|国元证券发布研报指，远大医药创新核药产品逐步上市将推动业绩持续增长，维持“买入”评级，目标价11.88港元，较现价有45.23%上涨空间。报告显示，公司25年中期实现总营业收入61.1亿港元，人民币口径同比增长2.0%。钇[90Y]微球注射液获批不可切除HCC适应症。该产品成为全球首个获FDA批准用于治疗不可切除HCC和结直肠癌肝转移双重适应症的SIRT产品。主要风险包括新产品研发进度低于预期及商业化进展不达预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216095359a6a74c86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216095359a6a74c86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512"],"gpt_icon":0},{"id":"2591983377","title":"中核集团攻克富集靶材辐照制备碘-131全链条技术 核药市场呈现高速增长（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2591983377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591983377?lang=zh_cn&edition=full","pubTime":"2025-12-16 08:41","pubTimestamp":1765845673,"startTime":"0","endTime":"0","summary":"平台充分发挥集团内部协同创新优势，整合中国原子能所属核理化院、核动力院、中核高通、中核二七二铀业，攻克富集 TeO 靶材辐照制备碘-131全产业链技术，形成了从碘-131前置核素制备、反应堆辐照到核药研发的完整环境友好型自主产业链。中国同位素与辐射行业协会秘书长郭丽莉介绍，截至2024年，国家药监局批准上市的放射治疗设备超90款，其中国产品牌占比超七成，彻底改变了此前依赖进口设备的局面。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216090508a6a717ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216090508a6a717ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1222","01763","BK1191","01244","BK1161"],"gpt_icon":0},{"id":"2591470614","title":"国元国际：维持远大医药(00512)“买入”评级 目标价格为11.88港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591470614","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591470614?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:52","pubTimestamp":1765788739,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国元国际发布研报称，远大医药创新产品逐步上市，推动业绩持续增长。国元国际主要观点如下：创新药推动收入增长25年中期实现总营业收入61.1亿港元，人民币口径同比增长2.0%；正常化溢利10.2亿港元，人民币口径同比下降5.0%。主要业务板块中，制药科技产品贡献最大，收入为港币38.45亿元，人民币口径同比上涨2.9%。盈利预测预计未来公司业绩将持续增长，预计2024-2026年收入分别为123.5亿和133.9亿、147.9亿港币；EPS分别为0.59、0.66、0.77港币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381550.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["00512"],"gpt_icon":0},{"id":"2591402266","title":"远大医药12月15日遭主力抛售313.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591402266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591402266?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:15","pubTimestamp":1765786516,"startTime":"0","endTime":"0","summary":"12月15日, 远大医药股价跌0.12%，报收8.17元，成交金额4648.4万元，换手率0.16%，振幅3.79%，量比0.78。远大医药今日主力资金净流出313.0万元，上一交易日主力净流出186.5万元。该股近5个交易日上涨0.74%，主力资金累计净流入411.1万元；近20日主力资金累计净流入2127.0万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161602a44d2abf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161602a44d2abf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2590512501","title":"远大医药12月11日主力净流入407.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590512501","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590512501?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:16","pubTimestamp":1765440960,"startTime":"0","endTime":"0","summary":"12月11日, 远大医药股价涨1.11%，报收8.20元，成交金额7666.7万元，换手率0.26%，振幅3.95%，量比1.85。远大医药今日主力资金净流入407.8万元，上一交易日主力净流出49.0万元。该股近5个交易日下跌0.24%，主力资金累计净流入558.1万元；近20日主力资金累计净流入2819.8万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162309953756f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162309953756f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2590565006","title":"港股异动 | 远大医药(00512)盘中涨超3% 中药创新药GPN01360国内II期临床达到终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2590565006","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590565006?lang=zh_cn&edition=full","pubTime":"2025-12-11 11:40","pubTimestamp":1765424423,"startTime":"0","endTime":"0","summary":"消息面上，远大医药近日公布，用于治疗抑郁症的中药创新药GPN01360在中国开展的Ⅱ期临床研究达到临床终点。远大医药表示，积极的临床研究数据为GPN01360后续的研发奠定了基础，并有望解决现有西药因副作用导致患者依从性差的难题，从而提高长期治疗的持续性和有效性，为提升抑郁症的临床治愈率带来新的方案。同时，GPN01360也将为中医药治疗抑郁症此类精神类疾病提供有力的循证医学证据，验证中成药的独特优势与科学价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","00512","BK1191","BK1161","159992","BK1574"],"gpt_icon":0},{"id":"2590699512","title":"又一突破，远大医药重磅抗抑郁1.1类新药迎来新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2590699512","media":"北京药研汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590699512?lang=zh_cn&edition=full","pubTime":"2025-12-11 08:01","pubTimestamp":1765411280,"startTime":"0","endTime":"0","summary":"近日，2025年12月8日，远大医药发布公告，集团用于治疗抑郁症的中药创新药GPN01360在中国开展的II期临床研究成功达到临床终点。其中佐力药业的乌灵胶囊2022年销售额达10亿元，证明了国产抗抑郁中药的市场价值。希望远大医药的GPN01360后续临床试验及注册申报工作顺利推进，若成功获批上市，将为广大抑郁症患者提供新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211080930a4410908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211080930a4410908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2590564574","title":"每日卖空追踪 | 远大医药 12月10日卖空量成交38.3万股，卖空比例为6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590564574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590564574?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355412,"startTime":"0","endTime":"0","summary":"远大医药北京时间12月10日，跌0.61%，卖空量成交38.3万股，较上一交易日减少77.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163254a43f9d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163254a43f9d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2590304413","title":"远大医药12月10日主力净流出49.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590304413","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590304413?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:15","pubTimestamp":1765354537,"startTime":"0","endTime":"0","summary":"12月10日, 远大医药股价跌0.61%，报收8.11元，成交金额4633.9万元，换手率0.16%，振幅1.72%，量比1.29。远大医药今日主力资金净流出49.0万元，上一交易日主力净流入551.7万元。该股近5个交易日上涨0.74%，主力资金累计净流入316.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2516.9万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016180495353461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016180495353461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2589391793","title":"远大医药(00512)：中药1类创新药GPN01360在中国开展的II期临床研究成功达到临床终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2589391793","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589391793?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:55","pubTimestamp":1765187758,"startTime":"0","endTime":"0","summary":"智通财经APP讯，远大医药 发布公告，近日，本集团用于治疗抑郁症的中药创新药GPN01360在中国开展的 II 期临床研究成功达到临床终点。此外，GPN01360安全性和耐受性较好，在整个试验期间未发现明显的毒副作用。前期近百人的人用经验研究表明，GPN01360在改善抑郁症状、缓解焦虑失眠及调理脾胃功能方面表现出良好疗效与安全性。因此，抑郁症的治疗仍存在较大未满足的临床需求，本集团的GPN01360有望为临床提供一种全新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","01360","06978","BK1161","BK1500","BK1191","BK1574","BK1137","00512"],"gpt_icon":0},{"id":"2590611353","title":"每日卖空追踪 | 远大医药 12月08日卖空量成交6.55万股，卖空比例为1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590611353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590611353?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182612,"startTime":"0","endTime":"0","summary":"远大医药北京时间12月08日，跌0.12%，卖空量成交6.55万股，较上一交易日减少38.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163125a72aad6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163125a72aad6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2590611803","title":"远大医药12月08日主力净流出468.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590611803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590611803?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181722,"startTime":"0","endTime":"0","summary":"12月08日, 远大医药股价跌0.12%，报收8.15元，成交金额5044.7万元，换手率0.17%，振幅2.82%，量比1.98。远大医药今日主力资金净流出468.9万元，上一交易日主力净流入116.5万元。该股近5个交易日下跌0.61%，主力资金累计净流入596.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2200.8万元，其中净流入天数为15日。该股主力净额占比0.02%，港股市场排名2436/2690。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816164297960a00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816164297960a00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2589841931","title":"每日卖空追踪 | 远大医药 12月05日卖空量成交5.15万股，卖空比例为1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589841931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589841931?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:30","pubTimestamp":1764923411,"startTime":"0","endTime":"0","summary":"远大医药北京时间12月05日，跌0.61%，卖空量成交5.15万股，较上一交易日减少83.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205163107952c71d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205163107952c71d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2588048711","title":"决胜港股升浪・致敬卓越力量，“第十届智通财经资本市场年会暨上市公司颁奖盛典”25项大奖揭晓!","url":"https://stock-news.laohu8.com/highlight/detail?id=2588048711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588048711?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:21","pubTimestamp":1764760876,"startTime":"0","endTime":"0","summary":"2025年12月3日，由国内领先的港美股资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办、财经公关综合服务提供商冬日暖阳 Donova 独家承办的 “第十届智通财经资本市场年会暨上市公司颁奖盛典” 在深圳盛大启幕。荣耀加冕：231 家企业及管理者斩获 25 项年度大奖当晚的颁奖典礼星光熠熠，各项大奖实至名归。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377197.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00384","00460","02525","01093","00136","00777","01070","02121","00451","00861","00875","00884","00855","00267","02256","00960","00300","00003","00666","09699","02279","00798","06160","00992","00020","00017","00699","02105","02419","02142","00363","00826","00382","02627","09878","09678","02498","00512","02511","00302","00867","00305","02380","02556","00999","01833","00656","00135"],"gpt_icon":1},{"id":"2588068364","title":"每日卖空追踪 | 远大医药 12月02日卖空量成交17.9万股，卖空比例为5.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588068364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588068364?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664211,"startTime":"0","endTime":"0","summary":"远大医药北京时间12月02日，跌0.73%，卖空量成交17.9万股，较上一交易日减少78.39%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163115978b6396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163115978b6396&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00512"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinagrandpharm.com","stockEarnings":[{"period":"1week","weight":0.0012},{"period":"1month","weight":-0.0109},{"period":"3month","weight":-0.0575},{"period":"6month","weight":-0.0296},{"period":"1year","weight":0.7961},{"period":"ytd","weight":0.7847}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0054},{"period":"3month","weight":-0.0322},{"period":"6month","weight":0.0918},{"period":"1year","weight":0.3006},{"period":"ytd","weight":0.2807}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"远大医药健康控股有限公司是一家主要从事制造及销售医药制剂及医疗器械的香港投资控股公司。该公司主要从事制造及销售医药制剂及医疗器械、生物技术产品及营养产品、精品原料药和其他产品。该公司的主要产品涵盖抗肿瘤、心血管急救制剂及高端心脑血管介入医疗器械、抗病毒抗感染、呼吸及五官科以及生物健康产品和精品原料药。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":0.087032},{"month":2,"riseRate":0.7,"avgChangeRate":0.108479},{"month":3,"riseRate":0.4,"avgChangeRate":0.019078},{"month":4,"riseRate":0.633333,"avgChangeRate":0.018767},{"month":5,"riseRate":0.466667,"avgChangeRate":0.084333},{"month":6,"riseRate":0.366667,"avgChangeRate":-0.048262},{"month":7,"riseRate":0.366667,"avgChangeRate":-0.015905},{"month":8,"riseRate":0.4,"avgChangeRate":0.007133},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.039275},{"month":10,"riseRate":0.5,"avgChangeRate":-0.014834},{"month":11,"riseRate":0.5,"avgChangeRate":0.085694},{"month":12,"riseRate":0.5,"avgChangeRate":-0.006218}],"exchange":"SEHK","name":"远大医药","nameEN":"GRAND PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"远大医药,00512,远大医药股票,远大医药股票老虎,远大医药股票老虎国际,远大医药行情,远大医药股票行情,远大医药股价,远大医药股市,远大医药股票价格,远大医药股票交易,远大医药股票购买,远大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"远大医药(00512)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供远大医药(00512)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}